UCLA Invents Newsletter
Newsletter published by: UCLA OIP-ISR April 2014


April 23, 2014
OIP-ISR Patent Strategy Session
Theme:  "Intellectual Property for Startups."

May 02, 2014
Theme:  "Crowdfunding for Entrepreneurs"

More Events


Dear Colleagues,

March was a great month for UCLA entrepreneurs. As detailed in the features below, one UCLA startup, NanoH2O was acquired by LG Chem for $200M, and another, C3 Jian raised $60M in Series D Financing. These events are illustrative of the growing culture of entrepreneurship at UCLA.

In addition, we hosted our 2nd Annual Medical Device Partnering event on March 11th, which attracted 240 registrants, more than double last year's number, and was universally lauded by those who attended. One comment that I received personally from a senior executive of a leading multinational medical device company was that it was the “best event of its kind in the world.”

We are excited by the success of our startups, and the increased engagement and interest from industry. We look forward to celebrating future successes!


Brendan Rauw
Associate Vice Chancellor and Executive Director of Entrepreneurship
UCLA Office of Intellectual Property & Industry Sponsored Research

C3 Jian Logo

UCLA Startup, C3 Jian, Closes $60M Series D Financing
Funds from the financing will be used to support continued clinical development of the company's lead product, a proprietary peptide-based antimicrobial therapy for tooth decay.

UCLA Startup, NanoH2O, Acquired by LG Chem for $200M

Los Angeles-based NanoH2O was established in 2005. The company had historically received investment from Khosla Ventures, Oak Investment Partners, BASF Venture Capital GmbH, Total Energy Ventures and Keytone Ventures.
SFGate Thumbnail

UC-Industry Collaborations Produce Trove of Patents

A recent study from UC Berkeley found that corporate-sponsored inventions at the University of California system over 15 years generated more patents and licenses than did those solely backed by the federal government.
Medical Device

Medical Device Purchasing in the Managed Care Era
A key panel discussion at the UCLA 2nd Annual Medical Device Partnering Conference explored how the purchasing practices of large health systems will impact adoption of new medical technologies.

 Intellectual Property Announcements

New U.S. Patents Awarded

  • 8,688,459 - Voice-controlled clinical information dashboard | N. Martin, et al.
  • 8,688,220 - Systems, devices and methods for the treatment of neurological . . .  | C. DeGiorgio, et al.
  • 8,686,712 - Time stretch enhanced recording scope | B. Jalali, et al.
  • 8,680,058 - Selectively targeted antimicrobial peptides and the use thereof | W. Shi, et al.
  • 8,675,346 - Mesoporous nanocrystalline film architecture for capacitive storage devices | S. Tolbert, et al.
  • 8,674,128 - Conductive organometallic framework | O. Yaghi, et al.
  • 8,674,101 - Nucleophilic fluorination of aromatic compounds | J. Barrio, et al.
  • 8,664,707 - Semiconductor device | K. Wang, et al.
  • 8,663,635 - N-cadherin: target for cancer diagnosis and therapy | R. Reiter


New UCLA Technologies Available for Licensing



UCLA Invents Newsletter, Vol. 2, No. 8

Subscribe and receive UCLA Invents by email: 

Send editorial comments and corrections to:  
Bob Nidever, Editor,  bnidever@research.ucla.edu

Contributors: Neil Bajpayee, Ben Dibling, Howard Chang

UCLA Invents is published by the UCLA Office of Intellectual Property & Industry Sponsored Research
11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu

Copyright © 2014 The Regents of the University of California. All Rights Reserved.

Share this